Arthur Allen
Newest Alzheimer’s drug slows disease — but costs over $25,000 per year. Who will pay for it?
The first drug purporting to slow the advance of Alzheimer’s disease is likely to cost the U.S. health care system ...
Breakthrough or boondoggle? Should the government fund development of medications for small fraction of the population resistant to antibiotics?
With time running out in the 2022 congressional session, a bipartisan coalition of lawmakers and infectious disease specialists is scrambling ...
Should Medicare routinely cover cost of $28,000-a-year Alzheimer’s drug Adumelm? Most medical professionals say ‘no’ but the pharmaceutical industry is fighting back
The drug industry, patient advocates, and congressional Republicans have all attacked federal officials’ decision to decline routine Medicare coverage for ...
COVID immunity: Is it stronger from infection or vaccination?
Dr. Aaron Kheriaty, a University of California-Irvine psychiatry professor, felt he didn’t need to be vaccinated against covid because he’d ...
COVID vaccine confusion: Why is there so much conflicting advice about if and when to get a booster shot?
On boosters, Americans have heard conflicting messages from various parts of the U.S. government. Yet, [Anthony] Fauci said, “there is ...
COVID vaccine rollout should draw on lessons of malaria and polio shot campaigns
The polio vaccine was one of the few the public greeted eagerly. Diseases like measles and whooping cough were familiar ...
Race matters for stem cell transplants
If you become ill with a blood cancer or other disease that requires a stem cell transplant, here’s an uncomfortable ...